Biomarkers in Critical Care,An Issue of Critical Care Clinics, 1st Edition
Author :
Edited by Mitchell Levy, MD, MCCM, FCCP
This issue of Critical Care Clinics, guest edited by Dr. Mitchell M. Levy, focuses on Biomarkers in Critical Care. This is one of four issues each year selected by the series consulting editor, Dr. John Kellum. Articles in this issue include, but are
...view more
This issue of Critical Care Clinics, guest edited by Dr. Mitchell M. Levy, focuses on Biomarkers in Critical Care. This is one of four issues each year selected by the series consulting editor, Dr. John Kellum. Articles in this issue include, but are not limited to: The History of Biomarkers; Biomarkers for Identifying Infection; Procalcitonin: Where Are We Now?; Soluble TREM-1: Diagnosis or Prognosis?; Lubricin as a Biomarker in Sepsis; Check Point Inhibitors and Their Role in Immunosuppression in Sepsis; Metabolomics and the Microbiome as Biomarkers in Sepsis; Lactate: Where Are We Now?; Predicting Renal Dysfunction; Biomarkers in the Evolution of ARDS; Biomarkers and RV Dysfunction; Biomarkers and Precision Medicine: State of the Art; The Use of Biomarkers for Population Homogeneity in Clinical Trials; and The Future of Biomarkers.
This issue of Critical Care Clinics, guest edited by Dr. Mitchell M. Levy, focuses on Biomarkers in Critical Care. This is one of four issues each year selected by the series consulting editor, Dr. John Kellum. Articles in this issue include, but are not limited to: The History of Biomarkers; Biomarkers for Identifying Infection; Procalcitonin: Where Are We Now?; Soluble TREM-1: Diagnosis or Prognosis?; Lubricin as a Biomarker in Sepsis; Check Point Inhibitors and Their Role in Immunosuppression in Sepsis; Metabolomics and the Microbiome as Biomarkers in Sepsis; Lactate: Where Are We Now?; Predicting Renal Dysfunction; Biomarkers in the Evolution of ARDS; Biomarkers and RV Dysfunction; Biomarkers and Precision Medicine: State of the Art; The Use of Biomarkers for Population Homogeneity in Clinical Trials; and The Future of Biomarkers.
Author Information
Edited by Mitchell Levy, MD, MCCM, FCCP, Systemwide Director, Critical Care Medicine Lifespan Health and Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Warren Alpert Medical School at Brown University, Providence, Rhode Island
Edited by Mitchell Levy, MD, MCCM, FCCP, Systemwide Director, Critical Care Medicine Lifespan Health and Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Warren Alpert Medical School at Brown University, Providence, Rhode Island
https://www.asia.elsevierhealth.com/biomarkers-in-critical-carean-issue-of-critical-care-clinics-9780323683142.html296449Biomarkers in Critical Care,An Issue of Critical Care Clinicshttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9780323683142_6.jpg71.0978.99USDInStock/Medicine & Surgery/Critical Care/Clinics/Medicine/Critical Care/Clinics/Clinics/Medicine/Critical Care/Japan Titles43351044388725505456850546665255041525984952631601418269243350884886536505455351451205259833This issue of Critical Care Clinics, guest edited by Dr. Mitchell M. Levy, focuses on Biomarkers in Critical Care. This is one of four issues each year selected by the series consulting editor, Dr. John Kellum. Articles in this issue include, but are not limited to: The History of Biomarkers; Biomarkers for Identifying Infection; Procalcitonin: Where Are We Now?; Soluble TREM-1: Diagnosis or Prognosis?; Lubricin as a Biomarker in Sepsis; Check Point Inhibitors and Their Role in Immunosuppression in Sepsis; Metabolomics and the Microbiome as Biomarkers in Sepsis; Lactate: Where Are We Now?; Predicting Renal Dysfunction; Biomarkers in the Evolution of ARDS; Biomarkers and RV Dysfunction; Biomarkers and Precision Medicine: State of the Art; The Use of Biomarkers for Population Homogeneity in Clinical Trials; and The Future of Biomarkers. This issue of Critical Care Clinics, guest edited by Dr. Mitchell M. Levy, focuses on Biomarkers in Critical Care. This is one of four issues each year selected by the series consulting editor, Dr. John Kellum. Articles in this issue include, but are not limited to: The History of Biomarkers; Biomarkers for Identifying Infection; Procalcitonin: Where Are We Now?; Soluble TREM-1: Diagnosis or Prognosis?; Lubricin as a Biomarker in Sepsis; Check Point Inhibitors and Their Role in Immunosuppression in Sepsis; Metabolomics and the Microbiome as Biomarkers in Sepsis; Lactate: Where Are We Now?; Predicting Renal Dysfunction; Biomarkers in the Evolution of ARDS; Biomarkers and RV Dysfunction; Biomarkers and Precision Medicine: State of the Art; The Use of Biomarkers for Population Homogeneity in Clinical Trials; and The Future of Biomarkers.00add-to-cart97803236831422019ProfessionalEdited by Mitchell Levy, MD, MCCM, FCCP20201Book152w x 229h (6.00" x 9.00")Elsevier240Nov 26, 2019IN STOCKEdited by <STRONG>Mitchell Levy</STRONG>, MD, MCCM, FCCP, Systemwide Director, Critical Care Medicine Lifespan Health and Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Warren Alpert Medical School at Brown University, Providence, Rhode IslandClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
